Global Receptor Tyrosine Protein Kinase ERBB 3 Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Receptor Tyrosine Protein Kinase ERBB 3 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Receptor Tyrosine Protein Kinase ERBB 3 by Country/Region, 2017, 2022 & 2028

2.2 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type

2.2.1 BA-0702

2.2.2 CDX-3379

2.2.3 Elgemtumab

2.2.4 ETBX-031

2.2.5 Others

2.3 Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type

2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

2.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Type (2017-2022)

2.4 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application

2.4.1 Non-Small Cell Carcinoma

2.4.2 Solid Tumor

2.4.3 Melanoma

2.4.4 Colorectal Cancer

2.4.5 Others

2.5 Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

2.5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Market Share by Application (2017-2022)

2.5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Application (2017-2022)

3 Global Receptor Tyrosine Protein Kinase ERBB 3 by Company

3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Company

3.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales by Company (2020-2022)

3.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2020-2022)

3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Revenue by Company (2020-2022)

3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2020-2022)

3.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2020-2022)

3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Company

3.4 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Location Distribution

3.4.2 Players Receptor Tyrosine Protein Kinase ERBB 3 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Receptor Tyrosine Protein Kinase ERBB 3 by Geographic Region

4.1 World Historic Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Geographic Region (2017-2022)

4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Revenue by Geographic Region

4.2 World Historic Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country/Region (2017-2022)

4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Revenue by Country/Region

4.3 Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth

4.4 APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth

4.5 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth

4.6 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth

5 Americas

5.1 Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country

5.1.1 Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022)

5.1.2 Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022)

5.2 Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type

5.3 Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region

6.1.1 APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2017-2022)

6.1.2 APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2017-2022)

6.2 APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type

6.3 APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 by Country

7.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022)

7.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022)

7.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type

7.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 by Country

8.1.1 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022)

8.2 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type

8.3 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3

10.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3

10.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 3

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors

11.3 Receptor Tyrosine Protein Kinase ERBB 3 Customer

12 World Forecast Review for Receptor Tyrosine Protein Kinase ERBB 3 by Geographic Region

12.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Region

12.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecast by Region (2023-2028)

12.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecast by Type

12.7 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca Plc

13.1.1 AstraZeneca Plc Company Information

13.1.2 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Plc Main Business Overview

13.1.5 AstraZeneca Plc Latest Developments

13.2 AVEO Pharmaceuticals, Inc.

13.2.1 AVEO Pharmaceuticals, Inc. Company Information

13.2.2 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AVEO Pharmaceuticals, Inc. Main Business Overview

13.2.5 AVEO Pharmaceuticals, Inc. Latest Developments

13.3 Etubics Corporation

13.3.1 Etubics Corporation Company Information

13.3.2 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Etubics Corporation Main Business Overview

13.3.5 Etubics Corporation Latest Developments

13.4 F. Hoffmann-La Roche Ltd.

13.4.1 F. Hoffmann-La Roche Ltd. Company Information

13.4.2 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.4.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.5 GamaMabs Pharma S.A.

13.5.1 GamaMabs Pharma S.A. Company Information

13.5.2 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GamaMabs Pharma S.A. Main Business Overview

13.5.5 GamaMabs Pharma S.A. Latest Developments

13.6 GlaxoSmithKline Plc

13.6.1 GlaxoSmithKline Plc Company Information

13.6.2 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Plc Main Business Overview

13.6.5 GlaxoSmithKline Plc Latest Developments

13.7 Hanmi Pharmaceuticals, Co. Ltd.

13.7.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information

13.7.2 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hanmi Pharmaceuticals, Co. Ltd. Main Business Overview

13.7.5 Hanmi Pharmaceuticals, Co. Ltd. Latest Developments

13.8 ImmunoGen, Inc.

13.8.1 ImmunoGen, Inc. Company Information

13.8.2 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 ImmunoGen, Inc. Main Business Overview

13.8.5 ImmunoGen, Inc. Latest Developments

13.9 Kolltan Pharmaceuticals, Inc.

13.9.1 Kolltan Pharmaceuticals, Inc. Company Information

13.9.2 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Kolltan Pharmaceuticals, Inc. Main Business Overview

13.9.5 Kolltan Pharmaceuticals, Inc. Latest Developments

13.10 Merrimack Pharmaceuticals, Inc.

13.10.1 Merrimack Pharmaceuticals, Inc. Company Information

13.10.2 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Merrimack Pharmaceuticals, Inc. Main Business Overview

13.10.5 Merrimack Pharmaceuticals, Inc. Latest Developments

13.11 Merus B.V.

13.11.1 Merus B.V. Company Information

13.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Merus B.V. Main Business Overview

13.11.5 Merus B.V. Latest Developments

13.12 Novartis AG

13.12.1 Novartis AG Company Information

13.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novartis AG Main Business Overview

13.12.5 Novartis AG Latest Developments

13.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

13.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Information

13.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business Overview

13.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Latest Developments

13.14 Sihuan Pharmaceutical Holdings Group Ltd.

13.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information

13.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Main Business Overview

13.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Latest Developments

13.15 Sorrento Therapeutics, Inc.

13.15.1 Sorrento Therapeutics, Inc. Company Information

13.15.2 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sorrento Therapeutics, Inc. Main Business Overview

13.15.5 Sorrento Therapeutics, Inc. Latest Developments

13.16 Symphogen A/S

13.16.1 Symphogen A/S Company Information

13.16.2 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Symphogen A/S Main Business Overview

13.16.5 Symphogen A/S Latest Developments

13.17 Takis S.r.l.

13.17.1 Takis S.r.l. Company Information

13.17.2 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

13.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Takis S.r.l. Main Business Overview

13.17.5 Takis S.r.l. Latest Developments

14 Research Findings and Conclusion

Table 1. Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Receptor Tyrosine Protein Kinase ERBB 3 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BA-0702

Table 4. Major Players of CDX-3379

Table 5. Major Players of Elgemtumab

Table 6. Major Players of ETBX-031

Table 7. Major Players of Others

Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & ($ million)

Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2022)

Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022)

Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2022)

Table 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2020-2022)

Table 20. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2020-2022)

Table 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Producing Area Distribution and Sales Area

Table 24. Players Receptor Tyrosine Protein Kinase ERBB 3 Products Offered

Table 25. Receptor Tyrosine Protein Kinase ERBB 3 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Geographic Region (2017-2022)

Table 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country/Region (2017-2022)

Table 34. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2017-2022)

Table 38. Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2017-2022)

Table 40. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

Table 42. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Table 44. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2017-2022)

Table 46. APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2017-2022)

Table 48. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

Table 50. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Table 52. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2017-2022)

Table 54. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2017-2022)

Table 56. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

Table 58. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Receptor Tyrosine Protein Kinase ERBB 3

Table 69. Key Market Challenges & Risks of Receptor Tyrosine Protein Kinase ERBB 3

Table 70. Key Industry Trends of Receptor Tyrosine Protein Kinase ERBB 3

Table 71. Receptor Tyrosine Protein Kinase ERBB 3 Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List

Table 74. Receptor Tyrosine Protein Kinase ERBB 3 Customer List

Table 75. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Forecast by Region

Table 77. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Application (2023-2028)

Table 95. AstraZeneca Plc Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 96. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 97. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. AstraZeneca Plc Main Business

Table 99. AstraZeneca Plc Latest Developments

Table 100. AVEO Pharmaceuticals, Inc. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 101. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 102. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. AVEO Pharmaceuticals, Inc. Main Business

Table 104. AVEO Pharmaceuticals, Inc. Latest Developments

Table 105. Etubics Corporation Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 106. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 107. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Etubics Corporation Main Business

Table 109. Etubics Corporation Latest Developments

Table 110. F. Hoffmann-La Roche Ltd. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 111. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 112. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. F. Hoffmann-La Roche Ltd. Main Business

Table 114. F. Hoffmann-La Roche Ltd. Latest Developments

Table 115. GamaMabs Pharma S.A. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 116. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 117. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. GamaMabs Pharma S.A. Main Business

Table 119. GamaMabs Pharma S.A. Latest Developments

Table 120. GlaxoSmithKline Plc Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 121. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 122. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. GlaxoSmithKline Plc Main Business

Table 124. GlaxoSmithKline Plc Latest Developments

Table 125. Hanmi Pharmaceuticals, Co. Ltd. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 126. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 127. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Hanmi Pharmaceuticals, Co. Ltd. Main Business

Table 129. Hanmi Pharmaceuticals, Co. Ltd. Latest Developments

Table 130. ImmunoGen, Inc. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 131. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 132. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. ImmunoGen, Inc. Main Business

Table 134. ImmunoGen, Inc. Latest Developments

Table 135. Kolltan Pharmaceuticals, Inc. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 136. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 137. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Kolltan Pharmaceuticals, Inc. Main Business

Table 139. Kolltan Pharmaceuticals, Inc. Latest Developments

Table 140. Merrimack Pharmaceuticals, Inc. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 141. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 142. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Merrimack Pharmaceuticals, Inc. Main Business

Table 144. Merrimack Pharmaceuticals, Inc. Latest Developments

Table 145. Merus B.V. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 146. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 147. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Merus B.V. Main Business

Table 149. Merus B.V. Latest Developments

Table 150. Novartis AG Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 151. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 152. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Novartis AG Main Business

Table 154. Novartis AG Latest Developments

Table 155. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 156. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 157. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business

Table 159. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Latest Developments

Table 160. Sihuan Pharmaceutical Holdings Group Ltd. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 161. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 162. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Sihuan Pharmaceutical Holdings Group Ltd. Main Business

Table 164. Sihuan Pharmaceutical Holdings Group Ltd. Latest Developments

Table 165. Sorrento Therapeutics, Inc. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 166. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 167. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Sorrento Therapeutics, Inc. Main Business

Table 169. Sorrento Therapeutics, Inc. Latest Developments

Table 170. Symphogen A/S Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 171. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 172. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. Symphogen A/S Main Business

Table 174. Symphogen A/S Latest Developments

Table 175. Takis S.r.l. Basic Information, Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Base, Sales Area and Its Competitors

Table 176. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Offered

Table 177. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Takis S.r.l. Main Business

Table 179. Takis S.r.l. Latest Developments

List of Figures

Figure 1. Picture of Receptor Tyrosine Protein Kinase ERBB 3

Figure 2. Receptor Tyrosine Protein Kinase ERBB 3 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BA-0702

Figure 10. Product Picture of CDX-3379

Figure 11. Product Picture of Elgemtumab

Figure 12. Product Picture of ETBX-031

Figure 13. Product Picture of Others

Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2021

Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2022)

Figure 16. Receptor Tyrosine Protein Kinase ERBB 3 Consumed in Non-Small Cell Carcinoma

Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Market: Non-Small Cell Carcinoma (2017-2022) & (K Pcs)

Figure 18. Receptor Tyrosine Protein Kinase ERBB 3 Consumed in Solid Tumor

Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Market: Solid Tumor (2017-2022) & (K Pcs)

Figure 20. Receptor Tyrosine Protein Kinase ERBB 3 Consumed in Melanoma

Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Market: Melanoma (2017-2022) & (K Pcs)

Figure 22. Receptor Tyrosine Protein Kinase ERBB 3 Consumed in Colorectal Cancer

Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Market: Colorectal Cancer (2017-2022) & (K Pcs)

Figure 24. Receptor Tyrosine Protein Kinase ERBB 3 Consumed in Others

Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 3 Market: Others (2017-2022) & (K Pcs)

Figure 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)

Figure 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application in 2021

Figure 28. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company in 2021

Figure 30. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Geographic Region in 2021

Figure 32. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2017-2022)

Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country/Region in 2021

Figure 34. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2022 (K Pcs)

Figure 35. Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2017-2022 ($ Millions)

Figure 36. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2022 (K Pcs)

Figure 37. APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2017-2022 ($ Millions)

Figure 38. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2022 (K Pcs)

Figure 39. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales 2017-2022 (K Pcs)

Figure 41. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2017-2022 ($ Millions)

Figure 42. Americas Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country in 2021

Figure 43. Americas Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country in 2021

Figure 44. United States Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region in 2021

Figure 49. APAC Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Regions in 2021

Figure 50. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country in 2021

Figure 57. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country in 2021

Figure 58. Germany Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Country in 2021

Figure 65. Egypt Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3 in 2021

Figure 71. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3

Figure 72. Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 3

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles